Vimta Labs Limited (NSE:VIMTALABS)
India · Delayed Price · Currency is INR 688.40
-5.05 (-0.73%)
Aug 1, 2025, 3:29 PM IST
United States Steel Market Cap
Vimta Labs has a market cap or net worth of 30.64 billion as of August 1, 2025. Its market cap has increased by 145.10% in one year.
Market Cap
30.64B
Enterprise Value
30.40B
Revenue
3.68B
Ranking
n/a
PE Ratio
41.76
Stock Price
$688.40
Market Cap Chart
Since January 10, 2002, Vimta Labs's market cap has increased from 19.85M to 30.64B, an increase of 154,276.94%. That is a compound annual growth rate of 36.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 30.64B | 38.59% |
| Dec 31, 2024 | 22.11B | 147.00% |
| Dec 29, 2023 | 8.95B | -7.56% |
| Dec 30, 2022 | 9.68B | 7.16% |
| Dec 31, 2021 | 9.04B | 134.75% |
| Dec 31, 2020 | 3.85B | 88.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,159.97B |
| Divi's Laboratories | 1,765.37B |
| Cipla | 1,259.61B |
| Apollo Hospitals Enterprise | 1,071.20B |
| Mankind Pharma | 1,062.98B |
| Zydus Lifesciences | 1,001.35B |
| Aurobindo Pharma | 672.57B |
| Fortis Healthcare | 636.20B |